Oncology
0 drugs are in development for Prostatic Neoplasms.
- Companies
- 0
- Clinical trials
- 39
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Prostatic Neoplasms pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Prostatic Neoplasms context
Oncology·MeSH: Prostatic Neoplasms (D011471)
Also known as: Neoplasm, Prostate, Neoplasm, Prostatic, Neoplasms, Prostate
Narrower concepts tracked separately: Prostate Cancer, Prostate Cancer (Adenocarcinoma), Cancer of the Prostate
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
Frequently asked questions
How many clinical trials target Prostatic Neoplasms?
There are 39 clinical trials targeting Prostatic Neoplasms tracked by BioSniper.
What is the prevalence of Prostatic Neoplasms?
The estimated prevalence of Prostatic Neoplasms is approximately 256.0 per 100,000 population.